|
Special Issue Introduction
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, with high incidence and poor prognosis. To overcome the poor prognosis, early diagnosis and optimal treatment of HCC are crucial. Therefore, it is critically important to identify specific patients who have a high risk of developing HCC, in order to optimize the allocation of limited HCC screening resources and enable cost-effective early diagnosis of HCC to prolong patient survival. Although most cases of HCC develop in patients with various types of chronic liver disease, the risk of developing HCC varies greatly, depending on individual diseases and the clinical status of each disease. To date, numerous clinical or molecular variable-based HCC risk models have been developed according to the liver disease etiology, severity, and molecular factors. However, none of these has been widely incorporated in the clinical care of liver disease patients yet. Therefore, further research is needed to develop more accurate and easy-to-apply risk models and to validate their universal application. The current special issue aims to review the most recent clinical and molecular risk models for HCC.
Submission Information
For Special issue guidelines, please refer to https://www.e-cmh.org/special/guidelines.php
For Author Instructions, please refer to https://www.e-cmh.org/authors/authors.php
For Online Submission, please login at https://mc04.manuscriptcentral.com/cmh
Contacts: Han Ah Lee, Associate editor, amelia86@naver.com
|